RESEARCH
More than 500 results
RESEARCH
-
SNOW SHADOW GYMNASTICS HIGH ALTITUDE CROSS-TRAINING
-$10 + 15% 1st
CO, 81401 MONTROSE, 535 SOUTH 1ST STREET
Snow Shadow Gymnastics began as a pilot research study. After 15 years is now considered as a front runner in the health field of High Altitude Cross-Training and fitness. Visit our company webite for more information in ways we can help assist or design your fitness needs and concerns.
-
We are northeast Ohio's largest school of graduate and professional programs. At CSU, you may choose from more than 80 graduate degrees, licensure and certificate programs as well as our new accelerated 4 plus 1 Bachelor's/Master's programs.
-
-
At The University of Texas at Tyler, we are creating solutions today for a better tomorrow. A culture of excellence provides a nurturing environment to prepare our students to be future problem solvers. We take great pride in a tradition of offering quality academic programs, expert faculty, fascinating student life and well-rounded service opportunities.
-
We do this by selling seeds, traits developed through biotechnology, and crop protection chemicals. Monsanto is an agricultural company. Farmers around the world use our innovative products to address on-farm challenges and reduce agriculture's overall impact on our environment. The Monsanto company works for the world's food producers, delivering products and solutions to help them reach their goals in ways that meet the world's growing food and fiber needs, conserve natural resources, and improve the environment.
-
Dohmen Capital Research Institute Inc. was founded in 1977 by Bert Dohmen as an economic and investment research firm. Over the past two decades, the firm’s services have achieved the highest acclaim. They are the most highly respected and sought-after advisory services for investors world-wide.The firm currently offers 10 services. These include a long-term advisory service for the mutual fund investor, which helps investors avoid the need for a money manager or financial planner. There are also fax and e-mail services for short term traders in stocks, options and short sales. Bert Dohmen’s WELLINGTON LETTER, has achieved numerous awards of distinction, and is read by serious investors, investment professionals and corporate CEO’s worldwide.
-
For more than 40 years, the Autism Research Institute (ARI) has devoted its work to conducting research and to disseminating the results of research on the triggers of autism and on methods of diagnosing and treating autism. We provide research-based information on Autism to parents and professionals around the world.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
SEQUOYAH RESEARCH CENTER
AR, 72204 LITTLE ROCK, UNIVERSITY OF ARKANSAS AT LITTLE ROCK 2801 S. UNIVERSITY
The Sequoyah Research Center supports the activities of the American Native Press Archives by providing physical space, technology and web site management, grant writing and other public and private funding efforts, administrative functions, and related activities.
-
Part of the mission of Sutter Gould Medical Foundation is to enhance the quality of life and advance medicine through medical research. Our Clinical Research Department, in conjunction with Gould physicians, conducts a variety of medical research projects to help us achieve that goal. Since 1978, our physicians, staff and patients have participated in studies including hypertension, irritable bowel syndrome, diabetes, cancer, congestive heart failure and many others. Many studies conducted at Sutter Gould are initiated by pharmaceutical companies testing new medications. All Sutter Gould research studies are controlled under the Food and Drug Administration and Department of Health and Human Services regulations. These agencies monitor the studies for safety, ethics, and scientific standards. Patients who participate in Sutter Gould studies do so on a voluntary basis.
-
The University of Idaho Research Park provides the perfect focus for the integration of business, research and development, and education. Our location and facilities provide: A lower cost of doing business University relationships Improved quality of life Opportunity for unlimited technical information and assistance A convenient location 10 miles from the University of Idaho Coeur d'Alene campus and 20 miles from downtown Spokane and its airport
-
JACKSONVILLE STATE UNIVERSITY - CENTER FOR ECONOMIC DEVELOPMENT & BUSINESS RESEARCH
AL, 36265 JACKSONVILLE, 700 PELHAM ROAD NORTH
The Center for Economic Development at JSU concentrates on providing specialized assistance to business and government. Examples of services provided include economic impact studies, marketing surveys, employee attitude assessment, training and personnel and pay plan development. In addition to the Center's consultants, the faculty is involved in providing expertise to area businesses and governments. The Center publishes a bi-monthly newsletter, JSU Economic Update, that provides data on the economy of northeast Alabama.
-
organization, educational organizations, educational resources, foundations, community civic organizations, resource, foundation
-
foundations, fundraising, resource, educational organizations, educational resources, organization
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
JDRF is the leader in research leading to a cure for type 1 diabetes in the world. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump - each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
JUVENILE DIABETES RESEARCH FOUNDATION
IA, 52406 CEDAR RAPIDS, 1026 A AVENUE NE, SUITE 113 PO BOX 3026
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
The Juvenile Diabetes Research Foundation is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its eventual and devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
More than 80 percent of JDRF's expenditures directly support research and research-related education. We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
We spearheaded breakthrough science in pursuit of devices, technologies, and potential therapies that will help people control their diabetes, keeping them healthier and complications-free until we find a cure. Our groundbreaking continuous glucose monitor research the first step in our journey to build an artificial pancreas not only generated excitement in the scientific community (and was named one of the top research advances of the year by ABC News), but also led to increased insurance reimbursement for CGM devices by most every major insurer. We catapulted the field of regenerative medicine to the forefront in diabetes research, creating momentum for more researchers to pursue this science with discovery after discovery of the regeneration and expansion capabilities of insulin-producing cells. More than 80 percent of JDRF's expenditures directly support research and research-related education.
-
social human services, organization, service organizations, organizations
-
In 1989, Research!America's founders came together with the realization that there was a vast deficiency in medical research funding — and that such a gap would be detrimental to Americans for years to come. Through their mutual belief in the fundamental importance of medical research, these visionaries formed the Research!America alliance. 1989: Research!America is formed with former Senator Lowell Weicker as president and CEO—and Edwin C. "Jack" Whitehead, founder of MIT's Whitehead Institute for Biomedical Research as founder and board chair. Other founders were Theodore Cooper, MD, then chairman and CEO of Upjohn Co., and medical research advocate Mary W. Lasker. 1990: Mary Woolley is named president of Research!America. The alliance makes its first call for NIH's budget to be doubled.
-
The Rhine Research Center is a hub for research and education on the basic nature of consciousness. The Center presents a wide range of educational offerings in which we attempt to draw together and present the most interesting and challenging current ideas on the nature and enhancement of consciousness. We present conferences, teach classes, and offer workshops, lectures, study groups, and other events. Some of these activities are face-to-face in our Durham NC headquarters, and some are web-based.
-
The Society for Social Work and Research is a non-profit (Federal ID Number 13-3768131), professional society incorporated in the State of New York in 1993. The Society is devoted to the involvement of social workers, other social work faculty, and social work students in research and to promotion of human welfare through research and research applications.
-
Whiplash and related whiplash injuries such as spinal injury, brain stem injury and associated disorders are the focus of Spine Research Institute of San Diego The Spine Research Institute of San Diego is a private research organization founded in 1984 by Arthur C. Croft, DC, MS, MPH. Since that time the institute has been actively engaged in the synthesis and dissemination of information relating to a wide range of injuries and conditions arising out of motor vehicle trauma, with a special focus on the most common forms of clinical conditions which impose the greatest public health burden today-a burden shared by private citizens, their health care providers, private insurers, automobile manufacturers, and state and local government.
-
The Whitlock Group has a dedicated team of engineers and sales associates that concentrate exclusively on videoconferencing solutions. We represent the full range of videoconferencing vendors, including industry-leaders Polycom, Tandberg and LifeSize. And, in addition to the standard videoconferencing gear, The Whitlock Group can specify optional add-on equipment to enhance the use of your system, including projection, displays, control systems, lighting, document cameras, lecterns and audio components. As a turnkey systems integration firm, The Whitlock Group can design any sized videoconferencing system for your organization, from a simple rollabout solution to multiple-location fully integrated conferencing suites.
-
Research Belton Hospital specializes in the following healthcare services: Bladder & Urinary Tract Care, Bone & Joint Care, Brain & Nervous System Conditions, Cancer Care, Emergency Care, Heart Care, ICU, Imaging Services, Laboratory Services, Pain Management, Pulmonary & Respiratory Care, Rehabilitation, Sleep Disorders, Stroke Care, Surgical Care, Women’s Care.
-
The Orthopaedic Research Institute has extensive facilities for the testing and evaluation of materials, devices, instruments and components. Evaluations are conducted as “bench top” (mechanical) tests and performance evaluation including tests in simulated biological and atmospheric environments and human cadaver testing. Consumer/user acceptance and focus group evaluations can also be conducted. In addition, these testing modalities are backed up with state of the art computational engineering design and analysis capabilities. Our interdisciplinary setting has proven to be a stimulating and productive venue for solving problems related to health, recreational and consumer products and devices.
-
Integrated Research (the people behind PROGNOSIS) develops and distributes performance monitoring and diagnostics software for business-critical IT infrastructures. Since Integrated Research began in 1988, PROGNOSIS software has been providing real-time, fault-tolerant management solutions for the business-critical computer systems that have evolved into what is known as HP NonStop server technology. In the late 90s PROGNOSIS evolved to apply its renowned deep diagnostics and reporting capabilities to Windows, UNIX, and Linux platforms server environments.
-
ACHRI's mission is to improve children's health, development, and well-being through high quality research. Advances in pediatric medicine begin with a vision for a future in which all children can grow up to be healthy adults. Arkansas Children's Hospital Research Institute (ACHRI) researchers share this common vision and have devoted their lives to making this vision, a reality.
